Skip to main content

John Hunter Peel Alexander

Professor of Medicine
Medicine, Cardiology
Duke Box 17969, Durham, NC 27715
300 W. Morgan Street, Durham, NC 27701

Keywords


Academic Medical Centers Acute Coronary Syndrome Acute Disease Administration, Oral Adolescent Adrenergic beta-Antagonists Adult African Americans Age Distribution Age Factors Aged Aged, 80 and over Algorithms Amiodarone Anastomosis, Surgical Angina, Unstable Angiography Angioplasty, Balloon, Coronary Angiotensin II Type 1 Receptor Blockers Angiotensin Receptor Antagonists Angiotensin-Converting Enzyme Inhibitors Animals Anti-Arrhythmia Agents Antibodies, Monoclonal Anticoagulants Antithrombin III Antithrombins Aptamers, Nucleotide Arginine Aspirin Atrial Fibrillation Benzimidazoles Biological Markers Blood Coagulation Blood Coagulation Tests Blood Glucose Blood Platelets Blood Pressure Blood Vessel Prosthesis Blotting, Western Body Mass Index Body Weight Brazil Carbazoles Cardiac Catheterization Cardiac Pacing, Artificial Cardiac Surgical Procedures Cardiopulmonary Bypass Cardiotonic Agents Cardiovascular Agents Cardiovascular Diseases Catheter Ablation Cause of Death Cells, Cultured Cerebrovascular Disorders Chest Pain Chi-Square Distribution Chromatography, Liquid Chronic Disease Clinical Protocols Clinical Trials as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Clopidogrel Cohort Studies Combined Modality Therapy Communication Comorbidity Confidence Intervals Confounding Factors (Epidemiology) Congresses as Topic Coronary Angiography Coronary Artery Bypass Coronary Artery Bypass, Off-Pump Coronary Artery Disease Coronary Disease Coronary Stenosis Coronary Vessels Costs and Cost Analysis Creatine Kinase Creatine Kinase, MB Form Cyclic N-Oxides DNA Data Collection Data Interpretation, Statistical Databases, Factual Defibrillators, Implantable Delivery of Health Care Device Removal Diabetes Complications Diabetes Mellitus Diabetes Mellitus, Type 2 Diagnosis, Differential Disease-Free Survival Dose-Response Relationship, Drug Double-Blind Method Down-Regulation Drug Administration Schedule Drug Combinations Drug Design Drug Prescriptions Drug Therapy, Combination Drug Toxicity E2F Transcription Factors Echocardiography Education, Medical, Continuing Electric Countershock Electrocardiography Electrophoresis, Polyacrylamide Gel Embolism Endoscopy Endothelium, Vascular Enoxaparin Enzyme Inhibitors Enzyme-Linked Immunosorbent Assay Epitopes Equipment Design Europe European Continental Ancestry Group Evidence-Based Medicine Exercise Test Factor IX Factor IXa Factor Xa Far East Feasibility Studies Female Fibrin Fibrinogen Degradation Products Fibrinolytic Agents Follow-Up Studies Gastrointestinal Diseases Genetic Engineering Genetic Predisposition to Disease Genetic Therapy Genotype Glycated Hemoglobin A Graft Occlusion, Vascular Graft Rejection Graft Survival Guideline Adherence Health Plan Implementation Health Services Accessibility Heart Block Heart Defects, Congenital Heart Diseases Heart Failure Heart Valve Diseases Heart Valve Prosthesis Heart Valve Prosthesis Implantation Hemodynamics Hemorrhage Heparin Heparin, Low-Molecular-Weight Hospitalization Hospitals, University Humans Hydrazones Hyperplasia Hypertension Hypoglycemic Agents Immunoglobulin Fab Fragments Immunoprecipitation Incidence Infusions, Intravenous Injections, Intravenous Injections, Subcutaneous Internal Medicine International Cooperation International Normalized Ratio Intracranial Hemorrhages Intraoperative Care Ischemia Isoenzymes Japan Kaplan-Meier Estimate Kidney Diseases Lidocaine Longitudinal Studies Male Medical Staff, Hospital Medicare Medication Errors Meta-Analysis Middle Aged Mineralocorticoid Receptor Antagonists Mitral Valve Insufficiency Models, Theoretical Monitoring, Physiologic Mortality Multicenter Studies as Topic Myoblasts, Skeletal Myocardial Ischemia Myocardial Revascularization Myocardium Naphthalenes Neoplasms New Zealand Nitric Oxide Synthase North Carolina Obesity Odds Ratio Oligonucleotides Organ Preservation Solutions Partial Thromboplastin Time Patient Readmission Patient Selection Peptide Fragments Peptides Percutaneous Coronary Intervention Pericardial Effusion Perioperative Care Peripheral Vascular Diseases Pharmacokinetics Physical Examination Physicians Pilot Projects Placebo Effect Placebos Platelet Aggregation Inhibitors Platelet Factor 4 Point-of-Care Systems Polysaccharides Postoperative Care Postoperative Complications Postoperative Hemorrhage Postoperative Period Practice Guidelines as Topic Practice Patterns, Physicians' Predictive Value of Tests Premedication Probability Prognosis Proportional Hazards Models Prospective Studies Prosthesis Design Protective Agents Protein Binding Protein Isoforms Protein Precursors Prothrombin Publication Bias Pulmonary Disease, Chronic Obstructive Pyrazoles Pyridazines Pyridines Pyridones Pyridoxal Phosphate Quality Assurance, Health Care Recombinant Proteins Recurrence Reference Values Regional Blood Flow Registries Regression Analysis Renin-Angiotensin System Reoperation Reproducibility of Results Research Design Retrospective Studies Risk Risk Assessment Risk Factors Risk Reduction Behavior Rupture, Spontaneous Saphenous Vein Sensitivity and Specificity Severity of Illness Index Sex Distribution Sex Factors Shock, Cardiogenic Signal Transduction Sodium Chloride Statistics Stents Streptokinase Stroke Sucralfate Surgical Procedures, Operative Surgical Wound Infection Surveys and Questionnaires Survival Survival Analysis Survival Rate Syndrome Tachycardia, Ventricular Tandem Mass Spectrometry Thrombin Thrombin Time Thromboembolism Thrombolytic Therapy Thromboplastin Thrombosis Ticlopidine Time Factors Tissue Plasminogen Activator Tissue and Organ Harvesting Transfection Transplantation, Autologous Transplants Treatment Failure Treatment Outcome Troponin Troponin I Troponin T Tunica Intima United States Urinary Bladder Diseases Vascular Diseases Vascular Patency Vascular Surgical Procedures Vasoconstrictor Agents Veins Vena Cava Filters Venous Thromboembolism Ventricular Dysfunction, Left Ventricular Fibrillation Warfarin World Health Wounds and Injuries Young Adult beta-Alanine omega-N-Methylarginine